Literature DB >> 10567557

LAT is required for tyrosine phosphorylation of phospholipase cgamma2 and platelet activation by the collagen receptor GPVI.

J M Pasquet1, B Gross, L Quek, N Asazuma, W Zhang, C L Sommers, E Schweighoffer, V Tybulewicz, B Judd, J R Lee, G Koretzky, P E Love, L E Samelson, S P Watson.   

Abstract

In the present study, we have addressed the role of the linker for activation of T cells (LAT) in the regulation of phospholipase Cgamma2 (PLCgamma2) by the platelet collagen receptor glycoprotein VI (GPVI). LAT is tyrosine phosphorylated in human platelets heavily in response to collagen, collagen-related peptide (CRP), and FcgammaRIIA cross-linking but only weakly in response to the G-protein-receptor-coupled agonist thrombin. LAT tyrosine phosphorylation is abolished in CRP-stimulated Syk-deficient mouse platelets, whereas it is not altered in SLP-76-deficient mice or Btk-deficient X-linked agammaglobulinemia (XLA) human platelets. Using mice engineered to lack the adapter LAT, we showed that tyrosine phosphorylation of Syk and Btk in response to CRP was maintained in LAT-deficient platelets whereas phosphorylation of SLP-76 was slightly impaired. In contrast, tyrosine phosphorylation of PLCgamma2 was substantially reduced in LAT-deficient platelets but was not completely inhibited. The reduction in phosphorylation of PLCgamma2 was associated with marked inhibition of formation of phosphatidic acid, a metabolite of 1,2-diacylglycerol, phosphorylation of pleckstrin, a substrate of protein kinase C, and expression of P-selectin in response to CRP, whereas these parameters were not altered in response to thrombin. Activation of the fibrinogen receptor integrin alpha(IIb)beta(3) in response to CRP was also reduced in LAT-deficient platelets but was not completely inhibited. These results demonstrate that LAT tyrosine phosphorylation occurs downstream of Syk and is independent of the adapter SLP-76, and they establish a major role for LAT in the phosphorylation and activation of PLCgamma2, leading to downstream responses such as alpha-granule secretion and activation of integrin alpha(IIb)beta(3). The results further demonstrate that the major pathway of tyrosine phosphorylation of SLP-76 is independent of LAT and that there is a minor, LAT-independent pathway of tyrosine phosphorylation of PLCgamma2. We propose a model in which LAT and SLP-76 are required for PLCgamma2 phosphorylation but are regulated through independent pathways downstream of Syk.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567557      PMCID: PMC84916          DOI: 10.1128/MCB.19.12.8326

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

1.  Essential role of LAT in T cell development.

Authors:  W Zhang; C L Sommers; D N Burshtyn; C C Stebbins; J B DeJarnette; R P Trible; A Grinberg; H C Tsay; H M Jacobs; C M Kessler; E O Long; P E Love; L E Samelson
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

2.  Tyrosine phosphorylation and translocation of LAT in platelets.

Authors:  S Sarkar
Journal:  FEBS Lett       Date:  1998-12-28       Impact factor: 4.124

3.  Signals elicited from human platelets by synthetic, triple helical, collagen-like peptides.

Authors:  M Achison; C Joel; P G Hargreaves; S O Sage; M J Barnes; R W Farndale
Journal:  Blood Coagul Fibrinolysis       Date:  1996-03       Impact factor: 1.276

4.  Evidence for the involvement of p59fyn and p53/56lyn in collagen receptor signalling in human platelets.

Authors:  S J Briddon; S P Watson
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

5.  Phosphatidylinositol 3,4,5-trisphosphate-dependent stimulation of phospholipase C-gamma2 is an early key event in FcgammaRIIA-mediated activation of human platelets.

Authors:  M P Gratacap; B Payrastre; C Viala; G Mauco; M Plantavid; H Chap
Journal:  J Biol Chem       Date:  1998-09-18       Impact factor: 5.157

6.  Tyrosine phosphorylation of SLP-76 is downstream of Syk following stimulation of the collagen receptor in platelets.

Authors:  B S Gross; J R Lee; J L Clements; M Turner; V L Tybulewicz; P R Findell; G A Koretzky; S P Watson
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

7.  Fetal hemorrhage and platelet dysfunction in SLP-76-deficient mice.

Authors:  J L Clements; J R Lee; B Gross; B Yang; J D Olson; A Sandra; S P Watson; S R Lentz; G A Koretzky
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

8.  LAT is required for TCR-mediated activation of PLCgamma1 and the Ras pathway.

Authors:  T S Finco; T Kadlecek; W Zhang; L E Samelson; A Weiss
Journal:  Immunity       Date:  1998-11       Impact factor: 31.745

9.  The p85 subunit of phosphatidylinositol 3-kinase associates with the Fc receptor gamma-chain and linker for activitor of T cells (LAT) in platelets stimulated by collagen and convulxin.

Authors:  J M Gibbins; S Briddon; A Shutes; M J van Vugt; J G van de Winkel; T Saito; S P Watson
Journal:  J Biol Chem       Date:  1998-12-18       Impact factor: 5.157

10.  SHP2-interacting transmembrane adaptor protein (SIT), a novel disulfide-linked dimer regulating human T cell activation.

Authors:  A Marie-Cardine; H Kirchgessner; E Bruyns; A Shevchenko; M Mann; F Autschbach; S Ratnofsky; S Meuer; B Schraven
Journal:  J Exp Med       Date:  1999-04-19       Impact factor: 14.307

View more
  42 in total

1.  T-cell signaling and immunopathologies.

Authors:  Christopher E Rudd
Journal:  Semin Immunopathol       Date:  2010-06       Impact factor: 9.623

2.  SH2 domain containing leukocyte phosphoprotein of 76-kDa (SLP-76) feedback regulation of ZAP-70 microclustering.

Authors:  Hebin Liu; Marco A Purbhoo; Daniel M Davis; Christopher E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-13       Impact factor: 11.205

3.  Evidence for the requirement of ITAM domains but not SLP-76/Gads interaction for integrin signaling in hematopoietic cells.

Authors:  Farhad Abtahian; Natalie Bezman; Regina Clemens; Eric Sebzda; Lan Cheng; Sanford J Shattil; Mark L Kahn; Gary A Koretzky
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

Review 4.  New Concepts and Mechanisms of Platelet Activation Signaling.

Authors:  Brian Estevez; Xiaoping Du
Journal:  Physiology (Bethesda)       Date:  2017-03

5.  Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation.

Authors:  M Endale; W M Lee; S M Kamruzzaman; S D Kim; J Y Park; M H Park; T Y Park; H J Park; J Y Cho; M H Rhee
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

6.  Reactive oxygen species play a critical role in collagen-induced platelet activation via SHP-2 oxidation.

Authors:  Ji Yong Jang; Ji Hyun Min; Yun Hee Chae; Jin Young Baek; Su Bin Wang; Su Jin Park; Goo Taeg Oh; Sang-Hak Lee; Ye-Shih Ho; Tong-Shin Chang
Journal:  Antioxid Redox Signal       Date:  2014-01-30       Impact factor: 8.401

7.  Reciprocal signaling by integrin and nonintegrin receptors during collagen activation of platelets.

Authors:  Hong Chen; Mark L Kahn
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

8.  The heptapeptide LSARLAF mediates platelet activation through phospholipase Cgamma2 independently of glycoprotein IIb-IIIa.

Authors:  Andrew C Pearce; Peter Wonerow; Stuart J Marshall; Jon Frampton; T Kent Gartner; Steve P Watson
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

9.  Fucoidan is a novel platelet agonist for the C-type lectin-like receptor 2 (CLEC-2).

Authors:  Bhanu Kanth Manne; Todd M Getz; Craig E Hughes; Osama Alshehri; Carol Dangelmaier; Ulhas P Naik; Steve P Watson; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

10.  Differential roles for the adapters Gads and LAT in platelet activation by GPVI and CLEC-2.

Authors:  C E Hughes; J M Auger; J McGlade; J A Eble; A C Pearce; S P Watson
Journal:  J Thromb Haemost       Date:  2008-09-27       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.